| Literature DB >> 27439463 |
Annerieke C van Groenestijn1, Esther T Kruitwagen-van Reenen1, Johanna M A Visser-Meily1, Leonard H van den Berg2, Carin D Schröder3.
Abstract
OBJECTIVE: To systematically identify and appraise evidence on associations between psychological factors (moods, beliefs, personality) and Health-related QoL (HRQoL) and/or global QoL in patients with Amyotrophic Lateral Sclerosis (ALS).Entities:
Keywords: Amyotrophic Lateral Sclerosis; Beliefs; Global QoL; Health-related QoL; Moods; Personality; Quality of life; psychological factors
Mesh:
Year: 2016 PMID: 27439463 PMCID: PMC4955215 DOI: 10.1186/s12955-016-0507-6
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Fig. 1Search flowchart
Patient and study characteristics
| Study characteristics | Patient characteristics | |||||||
|---|---|---|---|---|---|---|---|---|
| Author (date) | Country of research | Sample size |
|
| Time since onset (O)/ | ALSFRS | Diagnostic | Onset |
| Bremer (2004)T0 [ | U.S.A | 49 (29) | Longitudinal | 57.8 (13.0) | 34.9 (13.2) moO | 27.9 (6.3) | El Escorial | n.m |
| Chio (2004) [ | Italy | 80 (49) | Cross sectional | 59.8 (12.6; 26–81) | 2.1 (1.7; 1–7.8) yrO | 26.6 (9.5; 3–38) | El Escorial | n.m. |
| Clarke (2001) [ | Ireland | 26 (18) | Cross sectional | 63M (34–86) | 31.5 (4–156)M moD | 22.5M (11–36) | El Escorial | n.m |
| Dal Bello-Haas (2000) [ | U.S.A | 60 (38) | Cross sectional | 56.2 (12.2) | n.m | n.m | El Escorial | n.m. |
| Ganzini (1999) [ | U.S.A. | 100 (61) | Cross sectional | 54M (51.6–56.8) | 2.8 (2.0–3.6)M yrD | n.m | n.m | n.m |
| Gibbons (2013) [ | U.K. | 147 (90) | Cross sectional | 61 (11; 35–81) | n.m | 22.3 (9.5; 4–48) |
| n.m |
| Goldstein (2002) [ | U.K | 31 (19) | Cross sectional | 64.0 (11.9) | 15.9 (5.2) moD | n.m | El Escorial | n.m |
| Ilse (2015) [ | Germany | 49 (25) | Cross sectional | 63.8 (10.0) | 35.1 (36.3) moO | 32.6 (9.2) R | El Escorial | 33 % |
| Krampe (2008)T0 [ | Germany | 31 (19) | Longitudinal | 60.3 (10.4; 32.9–79.7) | 96.3 (70.5; 22.4–330.4) wkO | 27.0 (6.6; 12–38) | El Escorial | 19 % |
| Lule (2008)T0 [ | Germany | 39 (19) | Longitudinal | n.m | 43.9 (37.5; 0–170) moD | 19.9 (21.1; 0–39) | El Escorial | n.m |
| Matuz (2010) [ | Germany | 27 (15) | Cross sectional | 55.3 (11.1; 35–73) | 36 (4–129) moD | 17.4 (9.8; 0–36) |
| 7 % |
| Matuz T0 (2015) [ | Germany | 27 (15) | Longitudinal | 55.3 (11.1; 35–73) | 43.2 (30.5; 4–129) moD | 17.4 (9.8; 0–36) | El Escorial | 7 % |
| McCabe (2009) [ | Spain | 120 (72) | Cross sectional | 63.2 (12.4) | 5.7 (5.8)O yr | n.m | n.m | n.m |
| Montel (2012) [ | France | 49 (26) | Cross sectional | 63 (12) | 45 (28) moO | 28.2 (9.0)R | El Escorial | 22 % |
| Pagnini T0 (2015) [ | Italy USA | 197 (115) | Longitudinal | a | a | 30.6(9.9)SA | ‘self-declared’ | n.m |
| Peric (2010) [ | Serbia | 74 (45) | Cross sectional | 57 (11) | 29 (27) moO | 34 (8)R | El Escorial | n.m. |
| Pizzimenti (2013) [ | Italy | 36 (22) | Cross sectional | 63.7 (10.9) | 22 (14) moO | 35.1 (8.7) | El Escorial | 22 % |
| Robbins (2001)T0 [ | U.S.A | 60 (32) | Longitudinal | 58.5 (13.5; 27–83) | n.m | 28.1 (6.3; 12–39) | El Escorial | n.m |
| Simmons (2000) [ | U.S.A | 96 (52) | Cross sectional | 57.8 (23–80) | 31.8 (2 mo-10 year) moO | 26.6 (9–39) |
| n.m |
| Tramonti (2012) [ | Italy | 40 (30) | Cross sectional | 59.1 (10.9; 34–84) | n.m | 20.8 (8.3; 7–36) | n.m | n.m |
| Vignola (2008)TD [ | Italy | 29 (20) | Cross sectional | 63.6 (7.8; 44–78) | 11.7 (23.7; 2–43) moO | 33.1 (4.8; 22–39) | El Escorial | n.m |
| Winter (2010) [ | Germany | 37 (21) | Cross sectional | 59.6 (11.0) | 2.3 (1.9) yrO | n.m | El Escorial | n.m |
Note. Numbers are presented as means (SD; range), unless stated otherwise
Abbreviations: n.m not mentioned, M median instead of mean, yr year, mo months, wk weeks, ALSFRS Amyotrophic Lateral Sclerosis Functional Rating Scale, R ALSFRS-Revised, SA self-administered ALSFRS, T0 data from baseline measurement, TD data from diagnostic phase, O onset, D diagnosis
a time since diagnosis and age were reported in categories
Psychological factor measurements
| Psychological factors | Measurement and references | Number of items | Description | Scoring system | Generic/ALS-specific measure | References in this review |
|---|---|---|---|---|---|---|
| Anxiety | Hamilton rating scale for anxiety (HAM-A) | 14 | To assess the severity of symptoms of anxiety. Each of the items contains a number of symptoms, and each group of symptoms is rated on a scale. | 5-point scale. Total scores for anxiety range from 0 to 56. | Generic | [ |
| Hospital Anxiety and Depression Scale subscale anxiety (HADS-a) | 7 | To assess psychological distress in medically ill patients. The instrument concentrates on the psychic rather than the somatic symptoms of mood disorder in order to provide an assessment of mood independent of levels of physical disability in patients with medical illnesses. | 4-point scale. Total scores for anxiety range from 0 to 21 | Generic | [ | |
| Hospital Anxiety and Depression Scale subscale anxiety (HADS-a)— | 6 | To assess psychological distress in medically ill patients. The original HADS was modified with removal of question 11 of the original HADS “I feel restless as if I have to be on the move”. | 4-point scale. Total scores for anxiety range from 0 to 18. | ALS | [ | |
| State and Trait Anxiety Inventory (STAI) | 40 | To assess trait and state anxiety. | 4-point scale. Total scores for anxiety (STAIs and STAIt) range from 20 to 80. | Generic | [ | |
| Depression | Beck Depression Inventory (BDI) | 21 | To assess severity of depressive symptoms. | 4-point scale. Total scores for depression range from 0 to 63. | Generic | [ |
| Hamilton rating scale for depression (HAM-D) | 21 | To assess patient’s level of depression. | 8 items 5-point scale; 9 items 3-point scale. | Generic | [ | |
| Hospital Anxiety and Depression Scale subscale depression (HADS-d) | 7 | To assess psychological distress in medically ill patients. The instrument concentrates on the psychic rather than the somatic symptoms of mood disorder in order to provide an assessment of mood independent of levels of physical disability in patients with medical illnesses. | 4-point scale. Total scores for depression range from 0 to 21. | Generic | [ | |
| Hospital Anxiety and Depression Scale subscale depression (HADS-d) - | 6 | To assess psychological distress in medically ill patients. The original HADS was modified with removal of question 8: “I feel slowed down”, as it was felt likely that this would falsely exaggerate the measure of depression due to the physical symptoms of ALS. | 4-point scale. Total scores for depression range from 0 to 18. | ALS | [ | |
| Hospital Anxiety and Depression Scale subscale depression (HADS-d) - | 6 | To assess psychological distress in medically ill patients. The original HADS was modified with removal of question 8: “I feel slowed down”. | 4-point scale. Total scores for depression range from 0 to 16 (Two items in the depression subscale were recorded 0-1-1–2). | ALS | [ | |
| Depressive disorders: DSM-IV. American Psychiatric Association (2000) [ | 9 | To assess a major depressive disorder. | Score interpretation: | Generic | [ | |
| ALS-Depression-Inventory (ADI-12) | 12 | To assess depressive symptoms, specifically developed for ALS patients and addresses depressive symptoms excluding increasing physical impairments commensurate with ALS. | 4-point scale. Total scores for depression range from 12 to 48. | ALS | [ | |
| Zung Depression Scale (ZDS); | 20 | To assess depression | 4-point scale. Total scores for depression range from 20 to 80 | Generic | [ | |
| Mood | Profile of Mood State short-form (POMS-SF) McNair (1992) [ | 37 | To assess six states of mood: tension-anxiety, depression-dejection, anger-hostility, vigour-activity, fatigue-inertia, and confusion-bewilderment. | Abbreviated 37-item version of the original scale using the 5-point Likert Scale; 0 (not at all) to 4 (extremely). Total mood disturbance (TMD): sum of the subscales. | Generic | [ |
| Religiosity | Idler Index of Religiosity (IRR) | 4 | To assess the level of religiosity. It addresses both public and private aspects of religiosity: | Public religiousness: 1-item, 6-point scale; 1-item, 4-point scale | Generic | [ |
| Spirituality | Spiritual Well-being Scale (SWBS) (1) | 10 | To assess the level of spiritual well-being. | 6-point scale. Total scores of spiritual well-being range from 6 to 36. | Generic | [ |
| Spiritual Well-being Scale (SWBS) (2) | 20 | The scale consists of 10 religious well-being items (RWB) and 10 existential well-being items (EWB); spiritual well-being. | 6-point scale. Total scores (RWB + EWB) of spiritual well-being range from 20 to 120. | Generic | [ | |
| Mindfulness | Langer mindfulness scale (LMS) | 14 | Three domains associated with mindful thinking: novelty seeking, engagement and novelty producing. | Total scores range from 14–98, | Generic | [ |
| Hopelessness | Becks Hopelessness Scale (BHS) | 20 | To assess three major aspects of hopelessness: feelings about the future, loss of motivation, and expectations. | 2-point scale. Total scores of hopelessness range from 0 to 20. | Generic | [ |
| Perception of burden to others | Zarit Burden Inventory (ZBI) – | 3 | Three items of the original ZBI were revised to measure patient beliefs that their medical condition stressed, burdened, or caused financial hardship to their family. | 5-point scale. Total score of perception of burden to others (1 item) range from 0 to 4. | ALS | [ |
| Cognitive appraisal | Appraisal scale | 4 | To assess patients’ primary (motivational relevance, motivational congruence) and secondary appraisal (problem-focused and emotion-focused coping potential) | 9-point scale. Scores per item range from 1 to 9. Total scores are not mentioned. | Generic | [ |
| Coping | Motor Neuron Disease Coping Scale (MNDCS) – | 18 | To assess extent to which patients relied on the coping strategies. | 6-point scale. Total score for each type of coping was obtained by generating the mean score of the grouped scales. Ranges of total scores are not mentioned. | ALS | [ |
| Motor Neuron Disease Coping Scale (MNDCS/Cope-MND)— | 9 | To assess extent to which patients relied on the coping strategies. | 6-point scale. Ranges of total scores are not mentioned. Score interpretation: | ALS | [ | |
| The Brief COPE | 28 | Measures 14 dimensions of coping: distraction; active coping; denial; emotional support; instrumental support; disengagement; venting; positive reframing; planning; acceptance; humour; religion; self-blame; substance use. Each dimension consists of 2 items. | 4-point scale. No overall score. Score range per dimension ranges from 2 to 8, per item from 1 to 4. | Generic | [ | |
| Personality traits | NEO Five Factor Inventory (NEO-FFI) Costa (1992) [ | 60 | To assess the five dimensions of personality, postulated by the five-factor model of personality: neuroticism, extraversion, openness, agreeableness, and conscientiousness. | 5-point scale. Each of the five-factor subscales consists of 12 items, resulting in mean factor scores ranging from 0 to 4. | Generic | [ |
Global Quality of Life measurements
| Global QoL Measurement and reference | Number | Description | References in this review |
|---|---|---|---|
| The Schedule for the Evaluation of Quality of Life (SEIQoL) | 46 | SEIQoL assesses overall subjective QoL as judged by the patient in healthy or ill individuals. It is derived from a decision analysis technique known as judgement analysis, administered through a semi-structured interview. Patients rate their satisfaction with areas of their life by assessing three aspects of QoL. The patients have to 1) nominate the life areas (cues) which are important to their QoL; 2) rate their current level of functioning in each of these salient areas; and 3) rate the relative importance of each of their chosen cues. | [ |
| The Schedule for the evaluation of Quality of Life-Direct Weighting (SEIQoL-DW) | 15 | SEIQoL-DW is a shorter, direct-weight (DW) version of the SEIQoL, employs an alternative method of deriving cue weights using a colored disk. | [ |
| The McGill Quality of Life Questionnaire (MQOL) | 17 | MQOL assesses overall subjective QoL as judged by the patient. Subjects evaluate their lives over the past 2 days on five subscales using a 10-point semantic-differential format. Originally designed for cancer and HIV patients. It is not heavily weighted toward physical function and it includes an existential element. | [ |
| QoL-single-item question | 1 | A single-item question to assess patients self-perceived overall QoL. | [ |
| QoL-single-item question | 1 | A single-item question to assess patients self-perceived overall QoL. | [ |
Health-related Quality of Life measurements
| Health-related QoL Measurement and reference | Number | Description | References in this review |
|---|---|---|---|
| The 36-items Short Form of the Medical Outcomes Study questionnaire (SF-36) | 36 | SF-36 is a standardised, generic health-related quality of life measure. It consists of 36 items covering 8 dimensions. Each dimension is transformed into a 0–100 scale on the assumption that each question carries equal weight. High scores indicate good QoL. Four of these dimensions (limitations in physical functioning (PF); role limitations due to physical health problems (RP), bodily pain (BP), and general health perceptions (GH)) are summarized in the Physical Component Score (PCS), and four others (vitality (VT); social functioning (SF), role limitations due to emotional problems (ER), general mental health (MH)), in the Mental Component Score (MCS). | [ |
| Sickness Impact Profile (SIP) | 136 | SIP measures physical, mental and social aspects of health-related functioning; it contains statements regarding behaviour “sickness impact” and the individual is asked to respond by checking items that describe their health status. SIP contains 136 items in 12 categories and two dimensions (physical and psychosocial). Overall, category and dimension scores may be calculated from 0—100 (best). | [ |
| Sickness Impact Profile (SIP/ALS-19) | 19 | SIP/ALS-19 assess health-related QoL. It is a questionnaire consisting of 19 items from the full SIP (Sickness Impact Profile) believed to have the greatest impact on QoL, based on opinions of ALS clinical specialists. Extracted from the full SIP total score range from 0—100 (best). | [ |
| EuroQoL-5D | 5 | EuroQoL-5D assess health-related QoL. It consists of five questions that relate to five dimensions of health: mobility, self-care. usual activities, pain/discomfort, anxiety/depression. Each dimension is divided into three levels of severity (1, no problem; 3 severe problem). The EQ-5D-index score can be calculated. | [ |
| EQ VAS | 1 | EQ VAS assess health-related QoL. It is a visual analogue scale (VAS thermometer type) to rate patients current HRQoL ranging from 0 (worse imaginable health state) to 100 (best imaginable health state). | [ |
| World Health Organization Quality of Life brief questionnaire (WHOQoL-BREF) | 26 | WHOQoL-BREF assesses quality of life within the context of an individual’s culture, value systems, personal goals, standards and concerns. Generic instrument, measures QoL of life across 4 domains: physical health (7 items), psychological health (6 items), social relationships (3 items) and environment (8 items). Domain scores can be transformed to total scores from 0 (worse imaginable health state) to 100 (best imaginable health state). Two other items measure overall QoL and general health. Items are rated on a 5-point scale (low score of 1 to high score of 5) to determine a raw item score. Subsequently, the mean score for each domain is calculated, resulting in a mean score per domain that is between 4 and 20. Finally, this mean domain score is then multiplied by 4 in order to transform the domain score into a scaled score, with a higher score indicating a higher QoL. | [ |
| Quality of Life Index (QL-Index) | 5 | The Spitzer Qol Index (SQLI/ QLI/ QL-Index) assesses health-related QoL in palliative care populations. It covers five dimensions of quality of life: activity, daily living, health, support of family and friends, and outlook on life. Each dimension is rated on a three-point Likert scale (0 to 2), with the range of scores from 0 to 10. Lower scores reflect a higher QoL. | [ |
Methodological quality assessment
| Reference | Year | Internal validity | Control of drop out | External validity | Statistical validity | Proportion | Multi-collinearity | Confounding bias | Reporting | Total (max 8 points) |
|---|---|---|---|---|---|---|---|---|---|---|
| Bremer [ | 2004 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 5.0 |
| Chio [ | 2004 | 1 | 0.5 | 1 | 1 | 0 | 0 | 1 | 1 | 5.5 |
| Clarke [ | 2001 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 5.0 |
| Dal-Bello-Haas [ | 2000 | 1 | 0 | 0.5 | 1 | 0 | 0 | 0 | 1 | 3.5 |
| Ganzini [ | 1999 | 0 | 1 | 0.5 | 1 | 1 | 0 | 1 | 1 | 5.5 |
| Gibbons [ | 2013 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7.0 |
| Goldstein [ | 2002 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 3.0 |
| Ilse [ | 2015 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 4.0 |
| Krampe [ | 2008 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 4.0 |
| Lule [ | 2008 | 1 | 0 | 0.5 | 1 | 0 | 0 | 1 | 1 | 4.5 |
| Matuz [ | 2010 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 6.0 |
| Matuz [ | 2015 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 6.0 |
| McCabe [ | 2009 | 1 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 | 5.5 |
| Montel [ | 2012 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 4.0 |
| Pagnini [ | 2015 | 1 | 0.5 | 0.5 | 1 | 1 | 0 | 1 | 1 | 6.5 |
| Peric [ | 2010 | 1 | 0.5 | 1 | 1 | 0 | 1 | 1 | 1 | 6.5 |
| Pizzimenti [ | 2013 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8.0 |
| Robbins [ | 2001 | 1 | 0.5 | 0.5 | 1 | 1 | 0 | 1 | 1 | 6.0 |
| Simmons [ | 2000 | 1 | 0.5 | 1 | 1 | 0 | 0 | 0 | 1 | 4.5 |
| Tramtoni [ | 2012 | 1 | 0 | 0.5 | 1 | 0 | 0 | 1 | 1 | 4.5 |
| Vignola [ | 2008 | 1 | 0.5 | 1 | 1 | 0 | 0 | 1 | 1 | 5.5 |
| Winter [ | 2010 | 1 | 0.5 | 0.5 | 1 | 0 | 0 | 1 | 1 | 5.0 |
Note. 1 = internal validity: use of validated and reliable measures, 2 = control of patient drop-out: including nonresponse analysis and describing executive patients, 3 = external validity: specifying in/exclusion criteria and demographic and disease characteristics (diagnosis, age, gender, site of ALS onset, time since diagnosis, severity), 4 = statistical validity: testing for statistical significance, 5 = adequate sample size in relation to the number of determinants (univariate ratio 20:1 and multivariate ratio 10:1), 6 = control for multicollinearity, 7 = control for potential confounding variables, 8 = clear description of main finding [17]
Results of the bivariate and multivariate associations between psychological factors and QoL in patients with ALS
| Psychological Factor | Measure Psychological factor | Measure QoL | Time-points of assessment/F.U./trajectory | Bivariate | Multivariate | Ref. | Quality | |||
|---|---|---|---|---|---|---|---|---|---|---|
| MOOD |
| |||||||||
| Anxiety | HAM-A | HRQoL | SF-36 total | ns/nr | [ | 6.5 | ||||
| HAM-A | SF-36 PCS | ns/nr | ||||||||
| HAM-A | SF-36 MCS | ns/nr | ||||||||
| HADS-a1 | WHOQoL-BREF total | −0.53** | [ | 7.0 | ||||||
| Anxiety - Tension | POMS | WHOQoL-BREF total | nr | β = −0.47* | [ | 5.5 | ||||
| Anxiety | HADS-a | Global QoL | SEIQoL index score | ns/nr | [ | 5.0 | ||||
| HADS-a | SEIQoL-DW index score | ns/nr | [ | 3.0 | ||||||
| State anxiety | STAIsO | MQOL total | nr | s**/nr | [ | 5.5 | ||||
| STAIs | MQOL total | <1 mo after D. | nr | s**/nr | ||||||
| STAIs | MQOL total | >1 mo after D. | nr | s*/nr | ||||||
| Trait anxiety | STAIt | MQOL total | <1 mo after D. | nr | s**/nr | |||||
| STAIt | MQOL total | >1 mo after D. | nr | s* /nr | ||||||
| Depression | ||||||||||
| Depression—Dejection | POMS | HRQoL | WHOQoL-BREF total | nr | β = −0.24* | [ | 5.5 | |||
| Depression | HADS-d1 | WHOQoL-BREF total | −0.60** | β = −0.41* | [ | 7.0 | ||||
| HAM-D | SF-36 total | ns/nr | [ | 6.5 | ||||||
| HAM-D | SF-36 PCS | ns/nr | ||||||||
| HAM-D | SF-36 MCS | ns/nr | ||||||||
| ZDS | SF-36 total | −0.617** | [ | 4.5 | ||||||
| ZDS | QL-Index | s* /nr | β = −0.08* | [ | 8.0 | |||||
| BDI | EQ-5D index score | −0.430** | [ | 4.0 | ||||||
| BDIA | SF-36 MCS | nr | β = −0.391** | [ | 5.0 | |||||
| BDIA | SF-36 PCS | ns/nr | ||||||||
| BDIA | EQ-5D index score | nr | β = −0.272 | |||||||
| BDIA | EQ VAS | nr | β = −0.381* | |||||||
| BDI | HRCS | 1 mo F.U. | nr | s / nr | [ | 4.0 | ||||
| BDI | HRCS | 12 mo F.U. | nr | s**/nr | ||||||
| Depression x time | BDI | HRCS | over 12 mo | nr | ns | |||||
| Depression | ADI-12 | Global QoL | SEIQoL index score | −0.36* | [ | 4.5 | ||||
| DSM-IV | Single-item-question3 | ns/nr | ns / nr | [ | 5.5 | |||||
| ZDS | SEIQoL-DW index score | nr | s*/nr | [ | 5.5 | |||||
| ZDS | MQOL Single Item Score | nr | s*/nr | |||||||
| ZDS | SEIQoL index score | −0.205 | [ | 4.5 | ||||||
| ZDSo | MQOL total | nr | s**/nr | [ | 5.5 | |||||
| HADS-d | SEIQoL index score | ns/nr | [ | 5.0 | ||||||
| HADS-d2 | SEIQoL-DW index score | ns/nr | [ | 3.0 | ||||||
| BDI | Single-item-question4 | 1 mo F.U. | nr | s*/nr | [ | 4.0 | ||||
| BDI | Single-item-question4 | 12 mo F.U. | nr | s*/nr | ||||||
| Depression x time | BDI | Single item question4 |
| nr | ns | |||||
| Confusion - Bewilderment | POMS | Global QoL | WHOQoL-BREF total | nr | β = 0.33* | [ | 5.5 | |||
| BELIEFS | Religiosity | |||||||||
| Religiosity | IIR-tot | HRQoL | SIP/ALS-19 total | 0.169 | [ | 4.5 | ||||
| IIR-tot | SIP/ALS-19 total | 3 mo F.U. | nr | ns / nr | [ | 6.0 | ||||
| IIR-tot | SIP/ALS-19 total | 6 mo F.U. | nr | s***/nr | ||||||
| Religion - coping | Brief COPE | SF-36 PCS/SF-36 MCS | −0.26P | −0.01M | [ | 4.0 | ||||
| Religiosity | IIR-tot | Global QoL | MQOL total | 0.15 | [ | 5.0 | ||||
| IIR-tot | MQOL total | 3–4 mo F.U. | 0.28 | |||||||
| IIR-tot | MQOL total | 6–8 mo F.U. | 0.37** | |||||||
| IIR-tot | MQOL total | 9–12 mo F.U. | 0.33* | |||||||
| IIR-tot | MQOL total | 12–16 mo F.U. | 0.46** | |||||||
| IIR-tot | MQOL total | 3 mo F.U. | nr | ns / nr | [ | 6.0 | ||||
| IIR-tot | MQOL total | 6 mo F.U. | nr | ns / nr | ||||||
| IIR-tot | MQOL total | 0.221 | [ | 4.5 | ||||||
| IIR-tot | MQOL Single Item Score | 0.331** | ||||||||
| Religiosity Private | IIR-Pr | MQOL total | 0.13 | β = 0.05; R2 = 0% | [ | 5.0 | ||||
| IIR-Pr | MQOL total | 3–4 mo F.U. | 0.42** | β = 0.31** | ||||||
| IIR-Pr | MQOL total | 6–8 mo F.U. | 0.49** | β = 0.35** | ||||||
| IIR-Pr | MQOL total | 9–12 mo F.U. | 0.34* | β = 0.21 | ||||||
| IIR-Pr | MQOL total | 12–16 mo F.U. | 0.50** | β = 0.41***; R2 = | ||||||
| IIR-Pr | SEIQoL-DW index score | s*/nr | [ | 5.5 | ||||||
| Spirituality | [ | 5.0 | ||||||||
| Existential well-being | SWBS6 - EWB | HRQoL | SIP total | ns/nr | [ | 3.5 | ||||
| Religious well-being | SWBS6 - RWB | SIP total | −0.996** | |||||||
| Spiritual well-being | SWBS5 total | Global QoL | MQOL total | 0.08 | [ | 5.0 | ||||
| SWBS5 total | MQOL total | 3–4 mo F.U. | 0.08 | |||||||
| SWBS5 total | MQOL total | 6–8 mo F.U. | 0.17 | |||||||
| SWBS5 total | MQOL total | 9–12 mo F.U. | −0.12 | |||||||
| SWBS5 total | MQOL total | 12–16 mo F.U. | 0.54** | |||||||
| Mindfulness | ||||||||||
| Mindfulness | LMS | Global QoL | MQOL Single Item Score | nr | β = 0.06*** | [ | 6.5 | |||
| Mindfulness x time | LMS | MQOL Single Item Score |
| nr | β = 0.009 | |||||
| Coping | ||||||||||
| Positive coping strategies | MNDCS1 | HRQoL | WHOQoL-BREF total | 0.46** | β = 0.35*** | [ | 7.0 | |||
| Distraction | Brief COPE | SF-36 PCS/SF-36 MCS | 0.08P | −0.11M | [ | 4.0 | ||||
| Active coping | Brief COPE | SF-36 PCS/SF-36 MCS | −0.16P | 0.11M | ||||||
| Denial | Brief COPE | SF-36 PCS/SF-36 MCS | −0.15P | 0.23M | ||||||
| Emotional support | Brief COPE | SF-36 PCS/SF-36 MCS | 0.38P* | 0.10M | ||||||
| Instrumental support | Brief COPE | SF-36 PCS/SF-36 MCS | −0.31P | −0.02M | ||||||
| Disengagement | Brief COPE | SF-36 PCS/SF-36 MCS | 0.16P | 0.33M | ||||||
| Venting | Brief COPE | SF-36 PCS/SF-36 MCS | −0.10P | −0.38*M | ||||||
| Positive reframing | Brief COPE | SF-36 PCS/SF-36 MCS | −0.22P | 0.32M | ||||||
| Planning | Brief COPE | SF-36 PCS/SF-36 MCS | −0.23P | 0.11M | ||||||
| Acceptance | Brief COPE | SF-36 PCS/SF-36 MCS | −0.18P | 0.23M | ||||||
| Humor | Brief COPE | SF-36 PCS/SF-36 MCS | −0.15P | 0.25M | ||||||
| Self-blame | Brief COPE | SF-36 PCS/SF-36 MCS | 0.11P | −0.24M | ||||||
| Substance use | Brief COPE | SF-36 PCS/SF-36 MCS | 0.26P | −0.44*M | ||||||
| Problem management | MNDCS2 | Global QoL | SEIQoL index score | β = 0.44** | [ | 6.0 | ||||
| Problem management | MNDCS2 | SEIQoL index score | 3-6 mo F.U. | nr | β = 0.42** | [ | 6.0 | |||
| Problem appraisal | MNDCS2 | SEIQoL index score | nr | β = 0.15 | [ | 6.0 | ||||
| Emotion management | MNDCS2 | SEIQoL index score | nr | β = −0.26 | ||||||
| Emotional avoidance | MNDCS2 | SEIQoL index score | nr | β = 0.39* | ||||||
| Emotional avoidance | MNDCS2 | SEIQoL index score | 3–6 mo F.U. | nr | β = 0.28 | [ | 6.0 | |||
| Hopelessness | BHS | Global QoL | Single-item-question3 | 0.43*** | s**/nr | [ | 5.5 | |||
| Perception of burden to others | ZBI - | Global QoL | Single-item-question3 | 0.45*** | s*/nr | [ | 5.5 | |||
| Cognitive appraisal | ||||||||||
| Appraisal total | Appraisal scale | Global QoL | SEIQoL index score | nr |
| [ | 6.0 | |||
| Primary appraisal | Appraisal scale | SEIQoL index score | nr | β = −0.004 | ||||||
| Appraisal of coping potential | Appraisal scale | SEIQoL index score | nr | β = 0.15 | ||||||
| PERSONALITY | Agreeableness | NEO-FFI | Global QoL | Single-item-question4 | nr | β = 1.88* | [ | 4.0 | ||
| Agreeableness | NEO-FFI | HRQoL | HRCS | nr | β = 0.69* | |||||
| Agreeableness x time | NEO-FFI | Global QoL | Single-item-question4 |
| nr | β = −0.28* | ||||
| Agreeableness x time | NEO-FFI | HRQoL | HRCS |
| nr | β = −0.09* | ||||
| Neuroticism | NEO-FFI | Global QoL | Single-item-question4 | nr | ns/nr | |||||
| Extraversion | NEO-FFI | Single-item-question4 | nr | ns/nr | ||||||
| Openness | NEO-FFI | Single-item-question4 | nr | ns/nr | ||||||
| Conscientiousness | NEO-FFI | Single-item-question4 | nr | ns/nr | ||||||
Note. Significance levels: *p < 0.1; **p < 0.01; ***p < 0.001
Abbreviations: ns not significant, nr not reported, r correlation, β standardized regression coefficient, R 2 explained variance of the determinant, D diagnosis, A obtained from the author, F.U. follow-up, 1 modified version 1, 2 modified version 2, 3 self-developed single-item-question by Ganzini, 4 self-developed single-item-question by Krampe, 5 SWBS developed by Reed [51], 6 SWBS developed by Ellison [52], HRCS health-related QoL composite score, PCS physical component summary (P), MCS mental component summary (M), T0 data from baseline measurement, O overall (both < 1 month after diagnosis and > 1 month after diagnosis); Abbreviations of measurements: see Tables 2, 3 and 4